News & Updates

Does MS relapse after stopping ponesimod?

In a post hoc analysis of the OPTIMUM* long-term extension (OPTIMUM-LTE) study, discontinuation of ponesimod did not lead to a clinically meaningful disease reactivation or rebound effect in patients with relapsing multiple sclerosis (MS).

Dextrose gel to prevent transitional neonatal hypoglycaemia may do more harm than good

Administering a single dose of dextrose gel as prophylaxis against transitional neonatal hypoglycaemia does not help with the risk of neurocognitive impairment at early school age and even appears to have adverse effects on psychological well-being, according to a study.

Contraceptive progestogens carry meningioma risk

Progestogens used for contraception contribute to an increased risk of meningioma, as shown in a nested case-control study.

Semaglutide associated with reduced ICH risk in LVO treated with reperfusion therapy

Fenfluramine works in paediatric, adult patients with developmental/epileptic encephalopathies

In children and adults with developmental and epileptic encephalopathies (DEEs), treatment with fenfluramine appears to be effective with predictable tolerability, as shown in a real-world study.

Transcutaneous electrical nerve stimulation: Promising adjunct in stroke rehabilitation

Researchers from the Hong Kong Polytechnic University found that both transcutaneous vagus nerve stimulation (tVNS) and transcutaneous spinal cord stimulation (tSCS) are promising adjuncts to exercise for improving cognitive and upper limb function after stroke.